Zenas BioPharma, Inc. (ZBIO)
NASDAQ · Healthcare
Zenas BioPharma, Inc. Shareholder Equity 2023–2025
Zenas BioPharma, Inc. annual shareholder equity history from 2023 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Zenas BioPharma, Inc. shareholder equity as of December 31, 2025: 242.1M, a 22.50% decrease year-over-year.
- Zenas BioPharma, Inc. shareholder equity for 2025 were 242.1M, a 22.50% decrease from 2024.
- Zenas BioPharma, Inc. shareholder equity for 2024 were 312.5M, a 238.43% decrease from 2023.
- Zenas BioPharma, Inc. shareholder equity for 2023 were -225.7M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Zenas BioPharma, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $242 |
| 2024 | $312 |
| 2023 | $-226 |
Zenas BioPharma, Inc. Shareholder Equity — FAQ
Zenas BioPharma, Inc. (ZBIO) shareholder equity over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ZBIO's shareholder equity history?
The chart and table above show Zenas BioPharma, Inc.'s shareholder equity by year and by quarter, including the growth rate.